Stock listing
NASDAQ:UBX Unity Biotechnology Inc Stock
Follow Unity Biotechnology Inc into a list and get an email when it puts out news.
Delisted NASDAQ:UBX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:UBX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Unity Biotechnology Inc on 6ix
- Decks
- 6 decks · latest Mar 24, 2025
Where Unity Biotechnology Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:UBX · This page · Delisted | NASDAQ | United States | USD |
| OTC:UNBX · Delisted | OTC | United States | USD |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (March 2025) | Technical | 24 slides | Mar 24, 2025 |
| Technical Presentation (April 2023) | Technical | 21 slides | Apr 24, 2023 |
| Technical Presentation (March 2023) | Technical | 27 slides | Mar 27, 2023 |
| Technical Presentation (November 2022) | Technical | 30 slides | Nov 1, 2022 |
| Technical Presentation (August 2022) | Technical | 23 slides | Aug 12, 2022 |
| Technical Presentation (July 2021) | Technical | 26 slides | Jul 7, 2021 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Kristina Burow Other companies: Kardigan, Inc. (Director · Since at least Jun 22, 2026); Metsera, Inc. (Director · Since at least Jan 30, 2025); Boundless Bio, Inc. (Director · Since at least Mar 27, 2024); Neumora Therapeutics, Inc. (Director · Since at least Sep 14, 2023); Scholar Rock Holding Corporation (Director · Since at least May 23, 2018); Metacrine Inc (Director · Sep 15, 2020 – May 24, 2021 · Past); Beam Therapeutics Inc. (Director · Feb 5, 2020 – Jun 6, 2023 · Past); Vir Biotechnology, Inc. (Director · Oct 10, 2019 – May 21, 2020 · Past); Gossamer Bio, Inc. (Director · Feb 7, 2019 – Jun 8, 2023 · Past); Receptos Inc (Director · Aug 25, 2015 – Aug 25, 2015 · Past) | Director · May 2, 2018 – Jun 24, 2021 · Past |
| Paul L. Berns Other companies: Kardigan, Inc. (Director · Since at least Jun 17, 2026); Metsera, Inc. (Director · Since at least Jan 30, 2025); Neumora Therapeutics, Inc. (See Remarks, Director · Since at least Sep 14, 2023); EQRx Inc (Director · Dec 17, 2021 – Nov 9, 2023 · Past); Jazz Pharmaceuticals plc (Director · Nov 2, 2020 – Aug 5, 2021 · Past) | Director · Jun 24, 2021 – Jun 21, 2024 · Past |
| Camille D Samuels Other companies: Regenxbio Inc. (Director · Sep 16, 2015 – Jun 1, 2016 · Past); Achaogen Inc (Director · Mar 11, 2014 – Mar 11, 2014 · Past); Kythera Biopharmaceuticals Inc (Director · Oct 10, 2012 – Oct 1, 2015 · Past); Paratek Pharmaceuticals Inc (Director · May 9, 2006 – Feb 2, 2011 · Past) | Director · May 2, 2018 – Jun 21, 2024 · Past |
| Lynne Sullivan Other companies: Inozyme Pharma Inc (Director · Since at least Jul 23, 2020); Solid Biosciences Inc. (Chief Financial Officer at Unity Biotechnology · Since at least Jan 25, 2018); BiomX Inc. (Director · Nov 4, 2019 – Mar 1, 2023 · Past); Adicet Bio, Inc. (Director · Jan 25, 2018 – Jun 3, 2020 · Past) | CFO & Head of Corp. Dev. · Aug 1, 2020 – Apr 2, 2025 · Past |
| David Lacey Other companies: Nurix Therapeutics, Inc. (Director · Since at least Jul 23, 2020); Arcus Biosciences, Inc. (Director · Since at least May 21, 2020); Atreca Inc (Director · Jun 19, 2019 – Jun 13, 2023 · Past) | Director · May 2, 2018 – Jun 18, 2020 · Past |
| Gilmore O’Neill Other companies: Editas Medicine, Inc. (President and Chief Executive Officer · Since at least Jun 1, 2022); Aptinyx Inc (Director · Oct 19, 2021 – May 26, 2022 · Past); Sarepta Therapeutics, Inc. (EVP, R&D & CMO · Jun 7, 2018 – Mar 3, 2021 · Past) | Director · Dec 10, 2020 – Jun 21, 2024 · Past |
| Robert C Goeltz II Other companies: Arcus Biosciences, Inc. (Chief Financial Officer · Since at least Aug 1, 2020); CytomX Therapeutics, Inc. (Chief Financial Officer · Oct 7, 2015 – May 12, 2017 · Past) | Chief Financial Officer · May 2, 2018 – Jun 22, 2020 · Past |
| Alexander Azoy Other companies: Arcus Biosciences, Inc. (Chief Accounting Officer · Since at least Mar 9, 2023) | See Remarks · Sep 10, 2020 – Sep 13, 2020 · Past |
| Federico Grossi Other companies: Apellis Pharmaceuticals, Inc. (Chief Medical Officer · Apr 21, 2022 – Jan 5, 2023 · Past) | Chief Medical Officer · Jan 1, 2025 – Jan 6, 2025 · Past |
| Jamie Dananberg Other companies: Annexon, Inc. (EVP & CHIEF MEDICAL OFFICER · Since at least Jul 27, 2023) | Chief Medical Officer · May 2, 2018 – Mar 31, 2023 · Past |
All 17 people
| Person | Seat |
|---|---|
| Michael P Samar Other companies: Assembly Biosciences, Inc. (Chief Financial Officer · May 1, 2019 – Jul 25, 2022 · Past) | Director · May 25, 2022 – Jun 21, 2024 · Past |
| Tamara Tompkins Other companies: Amyris Inc (EVP, Gen'l Counsel & Secretary · Sep 27, 2010 – Apr 9, 2012 · Past) | See Remarks · May 2, 2018 – Jun 22, 2020 · Past |
| Yehia Hashad Other companies: Bausch + Lomb Corporation (EVP of R&D and CMO · Since at least May 5, 2022) | Director · Mar 8, 2025 – Mar 8, 2025 · Past |
| Alexander Hieu Nguyen | CLO and Head of Ops · Mar 8, 2021 – Apr 2, 2025 · Past |
| Anirvan Ghosh | Chief Executive Officer, Director · Mar 30, 2020 – Apr 2, 2025 · Past |
| Dan Marquess | Chief Scientific Officer · May 2, 2018 – Jun 22, 2020 · Past |
| Margo R Roberts | Director · Jun 24, 2022 – Jun 21, 2024 · Past |
Log in to ask 6ix AI your own questions about Unity Biotechnology Inc.